All right. With that, we're ready to kick things off. Next up, we have Repligen. Representing the company are Jason Garland and Jacob Johnson. Welcome, both of you. Yes. No, we were really happy with ...

Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 2.9% in the afternoon session after RBC Capital resumed coverage on the stock with an "outperform" rating and a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Shares of Kodiak Sciences, Repligen, and Biogen surged to annual highs amid positive company catalysts.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Repligen (RGEN) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.43 per share a year ago. These figures are ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Genmab A/S Sponsored ADR (GMAB) and Repligen (RGEN). But which of these two stocks is more attractive to value ...

I'm wrapping up the quarter for a lot of these sessions as a kickoff. For Repligen, it was a good quarter. It was 18% organic growth. Each of the key product areas was up double digits. Op margins ...